Bone morphogenetic protein-7 and Gremlin: New emerging therapeutic targets for diabetic nephropathy

Biochemical and Biophysical Research Communications

Volumn 383, Issue 1, 2009, Pages 1-3

  Zhang, Yanling ^a   Zhang, Qingxian ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

Bone morphogenetic protein 7; Diabetic nephropathy; Gremlin; Therapy

Indexed keywords

ANTIDIABETIC AGENT; GREMLIN; OSTEOGENIC PROTEIN 1; UNCLASSIFIED DRUG;

DIABETIC NEPHROPATHY; DRUG ACTIVATION; DRUG INHIBITION; DRUG MECHANISM; NONHUMAN; PRIORITY JOURNAL; SHORT SURVEY;

ANIMALS; BONE MORPHOGENETIC PROTEIN 7; DIABETIC NEPHROPATHIES; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE;

EID: 64949178482     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2009.03.086     Document Type: Short Survey

References (30)

1. Zimmet P., Alberti K.G., and Shaw J. Global and societal implications of the diabetes epidemic. Nature 414 (2001) 782-787
2. Bottinger E.P., and Bitzer M. TGF-beta signaling in renal disease. J. Am. Soc. Nephrol. 13 (2002) 2600-2610
3. Dolan V., Murphy M., Sadlier D., Lappin D., Doran P., Godson C., Martin F., O'Meara Y., Schmid H., Henger A., Kretzler M., Droguett A., Mezzano S., and Brady H.R. Expression of gremlin, a bone morphogenetic protein antagonist, in human diabetic nephropathy. Am. J. Kidney Dis. 45 (2005) 1034-1039
4. Dronavalli S., Duka I., and Bakris G.L. The pathogenesis of diabetic nephropathy. Nat. Clin. Pract. Endocrinol. Metab. 4 (2008) 444-452
5. Chen B., Athanasiou M., Gu Q., and Blair D.G. Drm/Gremlin transcriptionally activates p21(Cip1) via a novel mechanism and inhibits neoplastic transformation. Biochem. Biophys. Res. Commun. 295 (2002) 1135-1141
6. Fioretto P., Sutherland D.E., Najafian B., and Mauer M. Remodeling of renal interstitial and tubular lesions in pancreas transplant recipients. Kidney Int. 69 (2006) 907-912
7. Griffith D.L., Keck P.C., Sampath T.K., Rueger D.C., and Carlson W.D. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor beta superfamily. Proc. Natl. Acad. Sci. USA 93 (1996) 878-883
8. Helder M.N., Ozkaynak E., Sampath K.T., Luyten F.P., Latin V., Oppermann H., and Vukicevic S. Expression pattern of osteogenic protein-1 (bone morphogenetic protein-7) in human and mouse development. J. Histochem. Cytochem. 43 (1995) 1035-1044
9. Gazzerro E., and Canalis E. Bone morphogenetic proteins and their antagonists. Rev. Endocr. Metab. Disord. 7 (2006) 51-65
10. Zeisberg M., and Kalluri R. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr. Nephrol. 23 (2008) 1395-1398
11. Miyazaki Y., Ueda H., Yokoo T., Utsunomiya Y., Kawamura T., Matsusaka T., Ichikawa I., and Hosoya T. Inhibition of endogenous BMP in the glomerulus leads to mesangial matrix expansion. Biochem. Biophys. Res. Commun. 340 (2006) 681-688
12. Marchant K. Diabetes and chronic kidney disease: a complex combination. Br. J. Nurs. 17 (2008) 356-361
13. Wang S.N., Lapage J., and Hirschberg R. Loss of tubular bone morphogenetic protein-7 in diabetic nephropathy. J. Am. Soc. Nephrol. 12 (2001) 2392-2399
14. Wordinger R.J., Zode G., and Clark A.F. Focus on molecules: gremlin. Exp. Eye Res. 87 (2008) 78-79
15. Hruska K.A., Guo G., Wozniak M., Martin D., Miller S., Liapis H., Loveday K., Klahr S., Sampath T.K., and Morrissey J. Osteogenic protein-1 prevents renal fibrogenesis associated with ureteral obstruction. Am. J. Physiol. Renal. Physiol. 279 (2000) F130-F143
16. Kitten A.M., Kreisberg J.I., and Olson M.S. Expression of osteogenic protein-1 mRNA in cultured kidney cells. J. Cell. Physiol. 181 (1999) 410-415
17. Lappin D.W., McMahon R., Murphy M., and Brady H.R. Gremlin: an example of the re-emergence of developmental programmes in diabetic nephropathy. Nephrol. Dial. Transplant. 17 Suppl. 9 (2002) 65-67
18. Maciel T.T., Melo R.S., Schor N., and Campos A.H. Gremlin promotes vascular smooth muscle cell proliferation and migration. J. Mol. Cell. Cardiol. 44 (2008) 370-379
19. Massague J. The transforming growth factor-beta family. Annu. Rev. Cell Biol. 6 (1990) 597-641
20. McMahon R., Murphy M., Clarkson M., Taal M., Mackenzie H.S., Godson C., Martin F., and Brady H.R. IHG-2, a mesangial cell gene induced by high glucose, is human gremlin. Regulation by extracellular glucose concentration, cyclic mechanical strain, and transforming growth factor-beta1. J. Biol. Chem. 275 (2000) 9901-9904
21. Michos O., Goncalves A., Lopez-Rios J., Tiecke E., Naillat F., Beier K., Galli A., Vainio S., and Zeller R. Reduction of BMP4 activity by gremlin 1 enables ureteric bud outgrowth and GDNF/WNT11 feedback signalling during kidney branching morphogenesis. Development 134 (2007) 2397-2405
22. Morrissey J., Hruska K., Guo G., Wang S., Chen Q., and Klahr S. Bone morphogenetic protein-7 improves renal fibrosis and accelerates the return of renal function. J. Am. Soc. Nephrol. 13 Suppl. 1 (2002) S14-S21
23. Murphy M., Godson C., Cannon S., Kato S., Mackenzie H.S., Martin F., and Brady H.R. Suppression subtractive hybridization identifies high glucose levels as a stimulus for expression of connective tissue growth factor and other genes in human mesangial cells. J. Biol. Chem. 274 (1999) 5830-5834
24. Yanagita M. Modulator of bone morphogenetic protein activity in the progression of kidney diseases. Kidney Int. 70 (2006) 989-993
25. De Petris L., Hruska K.A., Chiechio S., and Liapis H. Bone morphogenetic protein-7 delays podocyte injury due to high glucose. Nephrol. Dial. Transplant. 22 (2007) 3442-3450
26. Mitu G.M., Wang S., and Hirschberg R. BMP7 is a podocyte survival factor and rescues podocytes from diabetic injury. Am. J. Physiol. Renal. Physiol. 293 (2007) F1641-F1648
27. Otani H., Otsuka F., Inagaki K., Takeda M., Miyoshi T., Suzuki J., Mukai T., Ogura T., and Makino H. Antagonistic effects of bone morphogenetic protein-4 and -7 on renal mesangial cell proliferation induced by aldosterone through MAPK activation. Am. J. Physiol. Renal. Physiol. 292 (2007) F1513-F1525
28. Wang S., and Hirschberg R. BMP7 antagonizes TGF-beta-dependent fibrogenesis in mesangial cells. Am. J. Physiol. Renal. Physiol. 284 (2003) F1006-F1013
29. Zeisberg M., Hanai J., Sugimoto H., Mammoto T., Charytan D., Strutz F., and Kalluri R. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury. Nat. Med. 9 (2003) 964-968
30. Zeisberg M., Shah A.A., and Kalluri R. Bone morphogenic protein-7 induces mesenchymal to epithelial transition in adult renal fibroblasts and facilitates regeneration of injured kidney. J. Biol. Chem. 280 (2005) 8094-8100